“Health & Growth — Working
together for a healthy Europe” calls for a new generation of partnerships
to address the EU’s growing health and competitiveness challenges. The paper
lays out a case for placing the pharmaceutical industry at the heart of
European economic reform and growth.
EFPIA President, Christopher
Viehbacher, CEO of Sanofi, said : “We need to better understand the
environmental and demographic factors driving healthcare spending… If we want
sustainable systems, we can’t revamp just one area; we need to address the
system as a whole.”
Richard Bergström, Director
General EFPIA, added: “We must start thinking outside the box and ensure our
industry is connected not just on debates about wellbeing, but also about jobs,
growth and economic stability. A new European life sciences strategy will be
vital to achieving the objectives of Europe 2020 and beyond.”
EFPIA is calling for greater
political collaboration to agree a comprehensive strategy for life sciences,
based on three “separate but interdependent pillars”:
1. Improvement of health
outcomes and removal of inequalities to better patient benefits;
2. Support for sustainable and predictable healthcare systems to speed access to medicines;
3. The building of a thriving innovative life sciences sector to promote European competitiveness.
2. Support for sustainable and predictable healthcare systems to speed access to medicines;
3. The building of a thriving innovative life sciences sector to promote European competitiveness.